{"id":115259,"name":"HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)","slug":"horizon-therapeutics-usa-inc-formerly-horizon-pharma-usa-inc","state":"IL","description":"Biopharmaceutical Development","totalSpending":1470000,"filings":22,"yearlySpending":[{"year":2018,"income":220000},{"year":2019,"income":280000},{"year":2020,"income":240000},{"year":2021,"income":250000},{"year":2022,"income":240000},{"year":2023,"income":240000}],"firms":["COVINGTON & BURLING LLP"],"lobbyists":["JOAN KUTCHER","GARY HEIMBERG","ED MCCLELLAN","GABRIEL NEVILLE","LAYTH ELHASSANI","JOHN MINOR"],"issues":["MMM","TAX","HCR",null],"sampleDescriptions":["Medicare reimbursement issue; 340B reform.","Tax reform.","Medicare reimbursement issue; orphan drug program.","Orphan drug tax issues.","Tax issues under the CARES Act.","Medicare coverage of home infusion drugs.","Medicare drug pricing reform.","Tax issues.","Drug pricing policies.","340B policy.","Drug pricing policies, including H.R. 2163, The Safe Step Act."],"years":[2018,2019,2020,2021,2022,2023]}